A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

Conditions: Non-Hodgkin Lymphoma Interventions: Drug: GLB-002 Sponsors: Hangzhou GluBio Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials